117 related articles for article (PubMed ID: 1941530)
1. Cytokine-activated human monocytes show differential cytotoxicity toward fresh and cultured Kaposi's sarcoma cells.
Philip R; Debs R
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1254-7. PubMed ID: 1941530
[TBL] [Abstract][Full Text] [Related]
2. Comparison of constitutive cytokine release in high and low histologic grade AIDS-related Kaposi's sarcoma cell strains and in sera from HIV+/KS+ and HIV+/KS- patients.
Bailer RT; Lazo A; Ng-Bautista CL; Hout BL; Ness GM; Hegtvedt AK; Blakeslee JR; Stephens RE; Brierley GP; Mallery SR
J Interferon Cytokine Res; 1995 May; 15(5):473-83. PubMed ID: 7648450
[TBL] [Abstract][Full Text] [Related]
3. Spindle cells from AIDS-associated Kaposi's sarcoma lesions express telomerase activity that is enhanced by Kaposi's sarcoma progression factors.
Barillari G; Franzese O; Comandini A; Bonmassar E; Ensoli B
Oncol Rep; 2010 Jul; 24(1):219-23. PubMed ID: 20514465
[TBL] [Abstract][Full Text] [Related]
4. Endogenous basic fibroblast growth factor is essential for cyclin E-CDK2 activity in multiple external cytokine-induced proliferation of AIDS-associated Kaposi's sarcoma cells: dual control of AIDS-associated Kaposi's sarcoma cell growth and cyclin E-CDK2 activity by endogenous and external signals.
Murakami-Mori K; Mori S; Nakamura S
J Immunol; 1998 Aug; 161(4):1694-704. PubMed ID: 9712033
[TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion.
Klimas N; Patarca R; Walling J; Garcia R; Mayer V; Moody D; Okarma T; Fletcher MA
AIDS; 1994 Aug; 8(8):1073-81. PubMed ID: 7986402
[TBL] [Abstract][Full Text] [Related]
6. Expression and cytokine regulation of glucocorticoid receptors in Kaposi's sarcoma.
Guo WX; Antakly T; Cadotte M; Kachra Z; Kunkel L; Masood R; Gill P
Am J Pathol; 1996 Jun; 148(6):1999-2008. PubMed ID: 8669484
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines induce the expression of basic fibroblast growth factor (bFGF) isoforms required for the growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements in the bFGF promoter.
Faris M; Ensoli B; Kokot N; Nel AE
AIDS; 1998 Jan; 12(1):19-27. PubMed ID: 9456251
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma.
Lunardi-Iskandar Y; Gill P; Lam VH; Zeman RA; Michaels F; Mann DL; Reitz MS; Kaplan M; Berneman ZN; Carter D
J Natl Cancer Inst; 1995 Jul; 87(13):974-81. PubMed ID: 7629884
[TBL] [Abstract][Full Text] [Related]
9. Thiol redox modulation of tumor necrosis factor-alpha responsiveness in cultured AIDS-related Kaposi's sarcoma cells.
Mallery SR; Landwehr DJ; Ness GM; Clark YM; Hohl CM
J Cell Biochem; 1998 Mar; 68(3):339-54. PubMed ID: 9518260
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice.
Samaniego F; Markham PD; Gallo RC; Ensoli B
J Immunol; 1995 Apr; 154(7):3582-92. PubMed ID: 7897237
[TBL] [Abstract][Full Text] [Related]
11. Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells.
Murakami-Mori K; Mori S; Bonavida B; Nakamura S
J Immunol; 1999 Mar; 162(6):3672-9. PubMed ID: 10092829
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients.
Dictor M; Rambech E; Way D; Witte M; Bendsöe N
Am J Pathol; 1996 Jun; 148(6):2009-16. PubMed ID: 8669485
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice.
Samaniego F; Markham PD; Gendelman R; Gallo RC; Ensoli B
J Immunol; 1997 Feb; 158(4):1887-94. PubMed ID: 9029130
[TBL] [Abstract][Full Text] [Related]
14. Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.
Kleinerman ES; Ceccorulli LM; Zwelling LA; Twilley T; Herberman RB; Jacob J; Gelmann EP
J Clin Oncol; 1985 Jul; 3(7):1005-12. PubMed ID: 3926955
[TBL] [Abstract][Full Text] [Related]
15. A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies.
Reiter Z; Ozés ON; Blatt LM; Sturzl M; Taylor MW
J Acquir Immune Defic Syndr (1988); 1992; 5(5):469-76. PubMed ID: 1560343
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of AIDS-Kaposi's sarcoma cells to Apo-2 ligand-induced apoptosis by actinomycin D.
Mori S; Murakami-Mori K; Nakamura S; Ashkenazi A; Bonavida B
J Immunol; 1999 May; 162(9):5616-23. PubMed ID: 10228045
[TBL] [Abstract][Full Text] [Related]
17. Distinct serum cytokines in AIDS-related skin diseases.
Breuer-McHam JN; Marshall GD; Lewis DE; Duvic M
Viral Immunol; 1998; 11(4):215-20. PubMed ID: 10189188
[TBL] [Abstract][Full Text] [Related]
18. Abnormal monocyte function in patients with Kaposi's sarcoma.
Braun DP; Harris JE
Cancer; 1986 Apr; 57(8):1501-6. PubMed ID: 3485009
[TBL] [Abstract][Full Text] [Related]
19. The soluble form of the IL-6 receptor (sIL-6R alpha) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130 is antagonistic for sIL-6R alpha-induced AIDS-KS cell growth.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
Int Immunol; 1996 Apr; 8(4):595-602. PubMed ID: 8722639
[TBL] [Abstract][Full Text] [Related]
20. Recognition of heterogeneous lymphokine-activated killer (LAK) receptors on Kaposi's sarcoma cells, endothelial cells, and monocytes/macrophages: evidence of distinct LAK-cell antigen on Kaposi's sarcoma cells--potential for use of LAK cells for immunotherapy.
Rahman MU; Mazumder A
J Clin Immunol; 1992 Jul; 12(4):281-8. PubMed ID: 1355096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
